Scarica l'app Stockscreener
23.27
0.17%
-0.04
Dopo l'orario di chiusura:
23.27
Precedente Chiudi:
$23.31
Aprire:
$23.52
Volume 24 ore:
1.77M
Relative Volume:
0.26
Capitalizzazione di mercato:
$11.56B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
58.17
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+4.58%
1M Prestazione:
+5.20%
6M Prestazione:
+73.66%
1 anno Prestazione:
+77.23%
Intervallo 1D:
$23.07
$23.52
Intervallo di 1 settimana:
$22.26
$23.70
Portata 52W:
$8.02
$23.70
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.27 | 11.58B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
128.18 | 56.27B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.42 | 45.87B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.78 | 43.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.89 | 30.20B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
486.00 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco Animal Health (ELAN) Is Up 8.6% After FDA Clears First Cat Screwworm Treatment – Has the Bull Case Changed? - Yahoo Finance
Can Elanco Animal Health Incorporated stock beat market expectations this quarterJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
Aug Decliners: Is Elanco Animal Health Incorporated stock dividend yield sustainableIPO Watch & High Return Trade Guides - BỘ NỘI VỤ
Elanco Animal Health Announces $245M Stock-For-Stock Acquisition Of Aratana Therapeutics - AOL.com
Elanco executive appointed as Neurizon’s board observer By Investing.com - Investing.com Canada
Elanco (NYSE: ELAN) Exec Justine Conway Joins Neurizon as Non-Voting Board Observer - Stock Titan
Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know - Finviz
Top Animal Health Stocks: Elanco Leads with Innovation, Zoetis Faces Headwinds - Investing.com Canada
Director Harrington Michael J bought $51,974 worth of shares (3,500 units at $14.85), increasing direct ownership by 5% to 81,094 units (SEC Form 4) - Quantisnow
Elanco (ELAN) Gains FDA Emergency Use Authorization for Credelio CAT - GuruFocus
Elanco (ELAN) Upgraded to Overweight, Targets $27 Per Share - GuruFocus
Elanco's Credelio CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats - Finviz
Elanco (ELAN) Gains FDA Emergency Use Approval for Cat Treatment - GuruFocus
Elanco stock rises after FDA emergency authorization for cat screwworm treatment - Investing.com Canada
Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats - Reuters
Elanco wins Overweight rating, Zoetis Sector Weight as KeyBanc reviews animal health space - Seeking Alpha
Elanco (NYSE: ELAN) gets first FDA EUA for New World screwworm treatment in cats - Stock Titan
Elanco Animal Health Stock Is Undervalued: AnalystElanco Animal Health (NYSE:ELAN) - Benzinga
Elanco Animal Health rises as KeyBanc joins bull camp - TradingView
This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarks2025 Sector Review & Low Risk High Reward Ideas - newser.com
How Elanco Animal Health Incorporated stock moves on employment dataJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Keybanc Initiates Coverage on ELAN with Overweight Rating and $2 - GuruFocus
Elanco to Participate in the Upcoming Investor Conferences - Investing News Network
KeyBanc initiates Elanco Animal Health stock with Overweight rating By Investing.com - Investing.com Canada
Elanco (ELAN) Receives Overweight Rating with Promising Growth P - GuruFocus
Elanco Animal Health (ELAN): Evaluating Valuation After Strong Q3 Earnings and Bullish Analyst Upgrades - Yahoo Finance
Can Elanco Animal Health Incorporated stock weather global recessionEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com
Elanco Animal Health (NYSE:ELAN) Upgraded by Argus to "Buy" Rating - MarketBeat
Primecap Management Co. CA Buys 1,543,279 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Can Elanco Animal Health Incorporated stock deliver surprise earnings beatJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Is Elanco Animal Health Incorporated (5EA) stock a momentum leaderLayoff News & Stock Timing and Entry Methods - newser.com
Elanco (NYSE: ELAN) to Join Evercore, Piper Sandler Investor Conferences Dec 3–4 - Stock Titan
Is Elanco Animal Health Incorporated stock positioned for secular growthWeekly Profit Recap & AI Driven Price Predictions - newser.com
Will Elanco Animal Health Incorporated stock benefit from sector leadershipInflation Watch & Consistent Return Investment Signals - newser.com
How Elanco Animal Health Incorporated stock reacts to global recession fearsJuly 2025 Closing Moves & Weekly Setup with ROI Potential - newser.com
Can Elanco Animal Health Incorporated stock surprise with earnings upsideEntry Point & High Conviction Trade Alerts - newser.com
Will Elanco Animal Health Incorporated stock deliver better than expected guidanceMarket Volume Report & AI Enhanced Trading Alerts - newser.com
Will Elanco Animal Health Incorporated (5EA) stock benefit from Fed rate cuts2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com
What to expect from Elanco Animal Health Incorporated in the next 30 days2025 Market Overview & Breakout Confirmation Alerts - newser.com
Argus reiterates buy rating on Elanco Animal Health stock, maintains $25 target By Investing.com - Investing.com South Africa
Will Elanco Animal Health Incorporated (5EA) stock hit Wall Street targetsInflation Watch & Risk Adjusted Swing Trade Ideas - newser.com
Argus reiterates buy rating on Elanco Animal Health stock, maintains $25 target - Investing.com Canada
Will Elanco Animal Health Incorporated (5EA) stock keep raising dividendsGap Down & Low Risk Growth Stock Ideas - newser.com
Why institutional investors increase stakes in Elanco Animal Health Incorporated stockEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Published on: 2025-11-19 15:40:18 - newser.com
Published on: 2025-11-19 14:41:06 - newser.com
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):